Season 2 Episode 13- Andrew Ruplin, PharmD
On today’s episode of The PQI Podcast we welcome Andrew Ruplin, PharmD. Andrew is an outpatient clinical oncology pharmacist at the University of Washington Medical Center and Seattle Cancer Care Alliance (SCCA). He obtained his PharmD from Drake University in Iowa before completing his PGY1 residency at the University of Chicago Medicine, and then went on to complete his PGY2 residency in oncology with the University of Washington Medical Center and Seattle Cancer Care Alliance. His disease specialties include gynecologic, neurologic, kidney, melanoma and non-melanoma skin, genitourinary, and breast cancers. I addition to his clinics, he is heavily involved with precepting clinical experiences, writing, and research projects in the residency program and serves as a student coordinator for general oncology advanced pharmacy practice experiences (APPEs). Outside of work, he enjoys the fantastic hiking and outdoor opportunities in Washington, movies, games, and exploring the food of Seattle. He can be found every weekend at the local dog parks with his Pembroke Welsh Corgi, Winnie.
Today we discuss his path to become an oncology pharmacist, his clinic and team processes, current challenges his clinic is facing, updates in GU oncology, and the process of authoring a PQI. The study Andrew references on the podcast can be found here: https://www.sciencedirect.com/science/article/pii/S1558767321001956.